Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.1.17 extracted from

  • Callewaert, L.; Aertsen, A.; Deckers, D.; Vanoirbeek, K.G.; Vanderkelen, L.; Van Herreweghe, J.M.; Masschalck, B.; Nakimbugwe, D.; Robben, J.; Michiels, C.W.
    A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria (2008), PLoS Pathog., 4, e1000019.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
MliC i.e. membrane bound lysozyme inhibitors of c-type lysozyme, isolated from Escherichia coli and Pseudomonas aeruginosa, possess lysozyme inhibitory activity and confer increased lysozyme tolerance upon expression in Escherichia coli. Related to a group of proteins with a common conserved COG3895 domain Gallus gallus
PliC i.e. periplasmic lysozyme inhibitor of c-type lysozyme, isolated by affinity chromatography from a periplasmic extract of Salmonella enteritidis and related to a group of proteins with a common conserved COG3895 domain Gallus gallus

Organism

Organism UniProt Comment Textmining
Gallus gallus P00698
-
-